David Escors Murugarren (ORCID:0000-0003-2828-4458)

Citée par

	Toutes	Depuis 2019
Citations	7530	4421
indice h	50	34
indice i10	98	79

960

480

240

720

2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202422 45 38 71 68 100 80 73 98 164 233 261 271 287 372 358 494 558 812 913 947 896 295

Accès public

Tout afficher

119 articles

13 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Grazyna KochanTeam LeaderAdresse e-mail validée de navarra.es
Karine BreckpotVrije Universiteit BrusselAdresse e-mail validée de vub.ac.be
Therese LiechtensteinPhD student, University College LondonAdresse e-mail validée de ucl.ac.uk
Ines DufaitLMCT/TROP at the VUBAdresse e-mail validée de vub.ac.be
David Guerrero-SetasResearcherAdresse e-mail validée de navarra.es
Christopher BricogneUCLAdresse e-mail validée de ucl.ac.uk
Kris ThielemansHoogleraar ImmunologieAdresse e-mail validée de vub.ac.be
F AlmazanCentro Nacional de Biotecnología (CNB-CSIC)Adresse e-mail validée de cnb.csic.es
Ander IzetaBioengineering Area, Tissue Engineering Laboratory. Instituto Biodonostia, Hospital Universitario DonostiaAdresse e-mail validée de biodonostia.org
Kevin Van der JeughtUniversity of MiamiAdresse e-mail validée de med.miami.edu
Sayandip MukherjeeUnilever Research & Development Centre, BangaloreAdresse e-mail validée de unilever.com
RONGTUAN LINMcGill UniversityAdresse e-mail validée de mcgill.ca
Roger J DavisH. Arthur Smith Professor & Chair, Program in Molecular Medicine, UMASS Medical SchoolAdresse e-mail validée de Umassmed.edu
Mala K MainiProfessor of Viral Immunology, UCLAdresse e-mail validée de ucl.ac.uk
Mariano EstebanProfesor de Investigación del CSICAdresse e-mail validée de cnb.csic.es
Joanna Laurson-DoubeMSIFAdresse e-mail validée de msif.org
Hugh GooldMacquarie University, NSW Department of Primary IndustriesAdresse e-mail validée de dpi.nsw.gov.au
Andrew M JacksonNottingham University, Duke University, Leeds University, Edinburgh University, Kennedy InstituteAdresse e-mail validée de nottingham.ac.uk
Mahdad NoursadeghiUniversity College LondonAdresse e-mail validée de ucl.ac.uk
Benny ChainUCLAdresse e-mail validée de ucl.ac.uk

Suivre

David Escors Murugarren (ORCID:0000-0003-2828-4458)

Principal Investigator, NavarraBiomed, University College London

Adresse e-mail validée de ucl.ac.uk - Page d'accueil

Immunology virology


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Lentiviral vectors in gene therapy: their current status and future potential D Escors, K Breckpot Archivum immunologiae et therapiae experimentalis 58, 107-119, 2010	489	2010
PD‐L1 co‐stimulation contributes to ligand‐induced T cell receptor down‐modulation on CD8⁺ T cells K Karwacz, C Bricogne, D MacDonald, F Arce, CL Bennett, M Collins, ... EMBO molecular medicine 3 (10), 581-592, 2011	333	2011
PDL1 signals through conserved sequence motifs to overcome interferon-mediated cytotoxicity M Gato-Cañas, M Zuazo, H Arasanz, M Ibañez-Vea, L Lorenzo, ... Cell reports 20 (8), 1818-1829, 2017	285	2017
PD1 signal transduction pathways in T cells H Arasanz, M Gato-Cañas, M Zuazo, M Ibañez-Vea, K Breckpot, ... Oncotarget 8 (31), 51936, 2017	276	2017
The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells A Lanna, SM Henson, D Escors, AN Akbar Nature immunology 15 (10), 965-972, 2014	266	2014
The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability D Escors, J Ortego, H Laude, L Enjuanes Journal of virology 75 (3), 1312-1324, 2001	248	2001
Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis F Almazán, ML Dediego, C Galán, D Escors, E Alvarez, J Ortego, I Sola, ... Journal of virology 80 (21), 10900-10906, 2006	247	2006
The intracellular signalosome of PD-L1 in cancer cells D Escors, M Gato-Cañas, M Zuazo, H Arasanz, MJ García-Granda, R Vera, ... Signal transduction and targeted therapy 3 (1), 26, 2018	231	2018
A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging A Lanna, DCO Gomes, B Muller-Durovic, T McDonnell, D Escors, ... Nature immunology 18 (3), 354-363, 2017	229	2017
Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome J Ortego, D Escors, H Laude, L Enjuanes Journal of virology 76 (22), 11518-11529, 2002	204	2002
Role of non-classical MHC class I molecules in cancer immunosuppression G Kochan, D Escors, K Breckpot, D Guerrero-Setas Oncoimmunology 2 (11), e26491, 2013	176	2013
Functional systemic CD 4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy M Zuazo, H Arasanz, G Fernández‐Hinojal, MJ García‐Granda, M Gato, ... EMBO molecular medicine 11 (7), e10293, 2019	167	2019
HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7 K Breckpot, D Escors, F Arce, L Lopes, K Karwacz, S Van Lint, M Keyaerts, ... Journal of virology 84 (11), 5627-5636, 2010	162	2010
Targeting dendritic cell signaling to regulate the response to immunization D Escors, L Lopes, R Lin, J Hiscott, S Akira, RJ Davis, MK Collins Blood, The Journal of the American Society of Hematology 111 (6), 3050-3061, 2008	150	2008
Tumour immunogenicity, antigen presentation, and immunological barriers in cancer immunotherapy D Escors New journal of science 2014, 2014	125	2014
Construction of stable packaging cell lines for clinical lentiviral vector production KS Sanber, SB Knight, SL Stephen, R Bailey, D Escors, J Minshull, ... Scientific reports 5 (1), 9021, 2015	114	2015
Organization of two transmissible gastroenteritis coronavirus membrane protein topologies within the virion and core D Escors, E Camafeita, J Ortego, H Laude, L Enjuanes Journal of virology 75 (24), 12228-12240, 2001	110	2001
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers K Broos, M Keyaerts, Q Lecocq, D Renmans, T Nguyen, D Escors, ... Oncotarget 8 (26), 41932, 2017	108	2017
Understanding LAG-3 signaling L Chocarro, E Blanco, M Zuazo, H Arasanz, A Bocanegra, ... International journal of molecular sciences 22 (10), 5282, 2021	105	2021
Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells JJ Pen, BD Keersmaecker, C Heirman, J Corthals, T Liechtenstein, ... Gene therapy 21 (3), 262-271, 2014	101	2014

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs